Exact Sciences
EXAS
#1186
Rank
C$26.91 B
Marketcap
C$141.85
Share price
0.32%
Change (1 day)
68.19%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): C-$7.63

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is C-$7.39. In 2024 the company made an earnings per share (EPS) of C-$7.74.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$7.63-1.38%
2024C-$7.74
2022C-$4.922.31%
2021C-$4.81-38.54%
2020C-$7.82692.96%
2019C-$0.99-50.69%
2018C-$2.0044%
2017C-$1.39-39.39%
2016C-$2.29-2.94%
2015C-$2.3637.1%
2014C-$1.7279.71%
2013C-$0.96-21.59%
2012C-$1.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Myriad Genetics
MYGN
C-$6.02-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
C$0.47-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
C$0.54-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C-$70.71 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$5.15-169.66%๐Ÿ‡ซ๐Ÿ‡ท France